Gene therapy for LPLD patients linked to lower frequency and severity of pancreatitis

news-medical.net
Gene therapy

Up to 6 years after receiving a single treatment with the gene therapy product lipoprotein lipase (LPL), patients with the debilitating genetic disease LPL deficiency (LPLD) had about 50% fewer episodes of pancreatitis than before receiving the treatment.

Read More